Posts

Posted on

Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced financial results for the third quarter ended September 30, 2020, and provided an overview of recent developments.

“We continued to make progress enrolling patients and activating trial sites in our Phase 1b trial of ATRC-101 during the third quarter and anticipate reporting initial summary data in the first half of 2021,” said John Orwin, Chief Executive Officer. “We recently presented preclinical data at SITC 2020 further highlighting the potential for ATRC-101 as a combination therapy with checkpoint inhibitors targeting the PD-1/PD-L1 axis. We expect to initiate combination studies with a checkpoint inhibitor as well as with chemotherapy, and to commence monotherapy expansion cohorts, in 2021.”

Recent Developments and Highlights

  • Screening in the Phase 1b first-in-human study evaluating ATRC-101 in patients with select solid tumor cancers is ongoing, and patients are currently being enrolled in the third dose cohort. To date, seven clinical trial sites have been activated, including two additional sites in the third quarter of 2020, and Atreca expects to announce initial summary data from the study in the first half of 2021. In addition to monotherapy expansion cohorts, clinical trials of ATRC-101 in combination with a PD-1 inhibitor and in combination with a chemotherapeutic are planned for 2021.
  • Atreca presented two posters describing preclinical evaluations of ATRC-101 at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020). The presentations provide insight into the cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101 as well as the potent single-agent activity of ATRC-101 in syngeneic mouse tumor models. Both posters are currently available on Atreca’s website.

Third
Quarter 2020
Financial Results

  • As of September 30, 2020, cash, cash equivalents and investments totaled $259.5 million.
  • Research and development expenses for the three months ended September 30, 2020 were $16.8 million, including non-cash share-based compensation expense of $1.6 million.
  • General and administrative expenses for the three months ended September 30, 2020 were $6.6 million, including non-cash share-based compensation expense of $1.9 million.
  • Atreca reported a net loss of $22.9 million, or basic and diluted net loss per share attributable to common stockholders of $0.66, for the three months ended September 30, 2020.

About
Atreca
, Inc.

Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as our lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients. For more information on Atreca, please visit www.atreca.com.

Forward-Looking Statements

This release contains forward-looking statements regarding our strategy and future plans, including statements regarding the development of ATRC-101 and our clinical and regulatory plans, and the timing thereof. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and are not historical facts and typically are identified by use of terms such as ”continued,” “anticipate,” “potential,” “expect,” “believe,” “planned,” and similar words, although some forward-looking statements are expressed differently. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the initiation, timing, progress and results of our research and development programs, preclinical studies, clinical trials, regulatory submissions, and other matters that are described in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) and available on the SEC’s website at www.sec.gov, including the risk factors set forth therein. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update any forward-looking statement in this press release, except as required by law.

 
 
Atreca, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
         
    September 30, December 31, 
      2020       2019  
         
ASSETS        
         
Current Assets
Cash and cash equivalents   $ 133,072     $ 157,954  
Investments     126,192       14,663  
Prepaid expenses and other current assets     4,898       3,502  
Total current assets     264,162       176,119  
Property and equipment, net     7,783       5,771  
Long-term investments     205       10,799  
Deposits and other     3,043       3,026  
Total assets   $ 275,193     $ 195,715  
         
LIABILITIES AND STOCKHOLDERS’ EQUITY
         
Current Liabilities
Accounts payable   $ 2,524     $ 2,133  
Accrued expenses     5,309       5,395  
Other current liabilities     1,442       419  
Total current liabilities     9,275       7,947  
Capital lease obligations, net of current portion     17       53  
Deferred rent     4,621       763  
Total liabilities     13,913       8,763  
         
         
Stockholders’ equity
Common stock     4       3  
Additional paid-in capital     488,593       351,039  
Accumulated other comprehensive income     117       16  
Accumulated deficit     (227,434 )     (164,106 )
Total stockholders’ equity     261,280       186,952  
Total liabilities and stockholders’ equity   $ 275,193     $ 195,715  
         

 
Atreca, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
       (unaudited)
                   
      Three Months Ended   Nine Months Ended
      September 30,   September 30,
        2020       2019       2020       2019  
Expenses                
  Research and development   $ 16,808     $ 12,812     $ 45,198     $ 40,447  
  General and administrative     6,614       4,864       20,195       10,919  
  Total expenses     23,422       17,676       65,393       51,366  
Interest and other income (expense)                
  Other income     353       619       987       1,805  
  Interest income     142       1,189       1,082       2,328  
  Interest expense     (1 )     (1 )     (3 )     (5 )
  Preferred stock warrant liability revaluation     —       —       —       (123 )
  Foreign exchange loss     —       (1 )     —       (1 )
  Loss on disposal of property and equipment     —       —       —       (7 )
Loss before Income tax expense     (22,928 )     (15,870 )     (63,327 )     (47,369 )
Income tax expense     (1 )     (1 )     (1 )     (2 )
Net loss   $ (22,929 )   $ (15,871 )   $ (63,328 )   $ (47,371 )
Net loss per share, basic and diluted   $ (0.66 )   $ (0.57 )   $ (2.09 )   $ (4.03 )
Weighted-average shares used in computing                
net loss per share, basic and diluted     34,723,888       27,949,682       30,313,047       11,747,825  
                   



Contacts

Atreca, Inc.
Herb Cross
Chief Financial Officer
[email protected]

Investors:
Alex Gray, 650-779-9251, ext. 251
[email protected]

Media:
Sheryl Seapy, 213-262-9390
[email protected] 
Source: Atreca, Inc.

Posted on

ARHT Media Grants Options

TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or the “Company”) (TSXV:ART), the global leader in the development, production and distribution of high-quality hologram content through its patented Holographic Telepresence technology, announced today that it has granted an aggregate of 677,500 options to various employees and one director under the stock option plan of the Company. The options are exercisable at a price of $0.30 per option and shall expire on November 11, 2025. The options shall vest in three equal tranches, with the first tranche vesting on the date of grant, the second tranche vesting on November 11, 2021 and the third tranche vesting on November 11, 2022, all subject to a four-month regulatory hold period.

Following the grant of the stock options, the Company has a total of 7,826,289 stock options outstanding representing approximately 8.4% of the outstanding common shares of the Company. The grant of options remains subject to TSX Venture Exchange approval.

About ARHT Media

ARHT Media’s patented holographic telepresence technology is a complete end-to-end solution that creates a sense of presence for audiences – as though the holographic presenter was actually live in the room. With no noticeable latency, ARHT Media makes two-way live communication with a 3D holographic presenter anywhere in the world possible. We can also playback pre-recorded content and 3D animations on our displays to deliver rich holographic experiences.

Connect with ARHT Media

Twitter: http://www.twitter.com/ARHTmedia
Facebook: http://www.facebook.com/ARHTmediainc
LinkedIn: http://www.linkedin.com/company/arht-media-inc-

For more information, please visit http://www.arhtmedia.com or contact the investor relations group at [email protected].

ARHT Media trades under the symbol “ART” on the Toronto Venture Stock Exchange.

ARHT Media Press Contact

Salman Amin
[email protected]

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, disclosure related to the Company’s sales funnel; the Company’s technol
ogy; the potential uses for the Company’s technology; the future planned events using the Company’s technology; the future success of the Company; the ability of the Company to monetize the Holographic Telepresence technology; the development of the Compan
y’s technology; and interest from parties in ARHT’s products. Generally, forward-looking information can be identified by the use of forward-looking
terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimat
es”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forw
ard-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by su
ch forward-looking information, including but not limited to: general business, economic and competitive uncertainties; regulatory risks; risks inherent in technology operations; and other risks of the technology industry. Although the Company has attempte
d to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assuran
ce that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does
not undertake to update any forward-looking information, except in accordance with applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACC
EPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Posted on

Apollo Gold Launches Initial Work at Libertador and Muylaque in Peru

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — Apollo Gold Corp. TSX.V: APGO (“Apollo” or the “Company“) announces that it has commenced an initial work program at the Libertador Project in Peru with work also scheduled to commence at the Muylaque Project shortly.

As announced on 13 October 2020, Apollo has entered into binding letters of intent relating to the acquisition of both projects, with the structure of such transactions enabling the ability to launch early work on the projects and the ability to move to Definitive Agreements as quickly as possible. The transactions also provide access to key relationships in Peru which, despite ongoing travel issues related to COVID-19, have enabled us to launch work programs utilizing a quality Peru based team.

Libertador

The Libertador Project is situated in the most prolific gold district in Peru with, Barrick owned, Lagunas Norte to the South West and Pan American owned La Arena to the North East. The largest gold mine in Peru, Yanacocha, is also situated due North of the Libertador Project. Libertador is currently owned by a subsidiary of AJE Group, a global multi-national corporation based out of Lima, which has methodically explored the concessions to date. Apollo is positioned to bring the next level of exploration and development to the Project, utilizing latest exploration techniques and technologies.

Nine main target zones have been identified at Libertador, including 2 key locations with a history of significant local mining of high-grade gold. Work to date has also indicated that the underlying mineralization at Libertador is the same as the surrounding mines across the district with significant potential to host silver-gold epithermal mineralization analogous to such mines.

As reported in the Apollo Gold press release of 13 October2020, historic sampling programs across the project returned the following results: within Libertadore II, rock grabs with: 9.3 grams per tonne (‘g/t’) Au and 102 g/t Ag; 3.3 g/t Au and 92 g/t Ag; 4.9 g/t Au and 49 g/t Ag; 5 g/t Au and 55 g/t Ag. Within the Huber Zone, rock grabs with 2.2 g/t Au and >100g/t Ag. Within the Jaunito Zone, rock grabs with 4.2, 3.9 and 2.2 g/t Au. Within the Raffo Zone, rock grabs with 3.74 g/t Au. Further details on the Libertador Project, including maps showing the location and details of the above samples can be found at the Company’s web site: www.apollogold.com/project/peru/.

Muylaque

The Muylaque Project is situated in the Southwestern Peru copper belt in a district that hosts many producing mines owned by major mining companies including Southern Peru Copper Cuajone Mine, Vale Quinsacolla, Anglo American Quellaveco and Hudbay Pinco Pinco Mine. The region has been seeing increased activity due to ongoing discoveries and also critically due to improving access and infrastructure. At Muylaque itself, a US$10 million government sponsored road has greatly improved access and now provides access to over half the claims with local trails providing access to the rest of the mineralized zones.

The Muylaque Project has been owned privately for many years and the focus of the family owned enterprise has been high-grade development of both the copper and gold zones occurring within the claims utilizing local processing infrastructure in the District which enables community mining of high-grade gold and copper.

The Muylaque project has multiple target areas including several where up to 30 tons of ore daily have been produced in zones with visible gold and other areas where there is the potential for a copper-gold porphyry system.

Previous companies with rights to this project, including First Quantum Minerals, undertook property wide sampling, geological mapping and airborne geophysical surveying. This work enabled the discovery of new mineralized zones and targets for initial drilling. As reported in the Apollo Gold press release of 13 October 2020, historic assays reported across the Property include the following historic results: Copper ‘Cu’ (0.4 percent (‘%’) to 21.24%), Silver (‘Ag’) (2 ounces (‘oz’) to 10 oz), and Gold (‘Au’) (0.16-3.5 oz). Further details on the Muylaque Project, including maps showing the location and details of the above samples can be found at the Company’s web site: www.apollogold.com/project/peru/.

Initial Work Program

Field crews have been working at Libertador and will move shortly to Muylaque. This initial program will provide early results and feedback on both properties and will include sampling work to validate and expand on previously reported assays and to target potential initial drill sites. It will also encompass site visits for both properties for 43-101 purposes and enable the completion of appropriate technical reports on each project in short order. It will also provide recommendations for larger work programs to commence in the New Year, thereby fast-tracking exploration and ensuring that as soon as definitive agreements are executed, the Company is in position to launch larger, more focused work programs at each property.

Simon Clarke, CEO of Apollo Gold stated, “we are pleased to be able to conduct this initial work program in such short time-lines. The results will position us to move quickly to Definitive Agreements in relation to Libertador and Muylaque and will enable us to hit the ground running early in the New Year with more comprehensive work programs and the goal of confirming initial drill targets as quickly as possible. The ability to launch work programs at this time is a testament to the strength of our relationships on the ground in Peru.”

APOLLO GOLD CORP.


“Simon Clarke”


Simon Clarke, Chief Executive Officer

About Apollo Gold Corp. (TSX.V: APGO)
Apollo Gold has assembled a team that is exploring for world class gold deposits in tier-one jurisdictions with an initial focus on Peru and Chile which both combine exceptional geology with supportive regulatory and fiscal regimes. Positioned for a prolonged gold cycle, the Company has secured rights to highly prospective projects in both countries. In Chile, the Company’s initial project encompasses 5,329-hectares in the heart of the Republic of Chile’s prolific El Indio Gold Belt surrounded by some of the largest gold companies/mines in the world. The Company has also entered into binding letters of intent to acquire two highly prospective properties in Peru with a history of significant community gold production and in mining districts with numerous large-scale mines and deposits. Apollo’s team offers global resource sector experience focused on exploration and development with a track-record in advancing projects and creating shareholder value. For more information visit: www.apollogold.com.

The technical content of this news release has been reviewed and approved by Dean Besserer, P.Geol., Vice President Exploration of the Company and a Qualified Person as defined by National Instrument 43- 101.

For further information, please contact
Apollo Gold Corp.
Simon Clarke
Tel: +1 (604) 551-9665
[email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding “Forward-Looking” Information

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in the Company’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will”, “could”, “plan”, “estimate”, “expect”, “intend”, “may”, “potential”, “appear”, “should,” and similar expressions, are forward-looking statements.

Although Apollo Gold Corp. has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and the Company disclaims any intention or obligation to update or revise such information, except as required by applicable law.

Posted on

Fifth Street Asset Management Inc. Announces a Distribution in Kind of 0.026239 shares of OCSI and Provides a Business Update

WEST PALM BEACH, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) — Fifth Street Asset Management Inc. (OTCPK:FSAM) (“FSAM” or the “Company”) today announced that on November 10, 2020 its Board of Directors declared a distribution in kind of 0.026239 shares of Oaktree Strategic Income (NASDAQ:OCSI) per share, on November 30, 2020 to stockholders of record of FSAM Class A Common Stock as of November 18, 2020.  

The Board anticipates making a final liquidating distribution in December 2020.

About Fifth Street Asset Management Inc.

Prior to the closing of the asset sale to Oaktree Capital Management, L.P. on October 17, 2017, Fifth Street Asset Management Inc. was a nationally recognized credit-focused asset manager.

Forward-Looking Statements

Some of the statements in this press release may include, and certain oral statements made by our representatives from time to time may include, forward-looking statements that reflect current views with respect to future events and financial performance. Statements that include the words “should,” “expect,” “will,” “intend” and similar statements of a future or forward-looking nature identify forward-looking statements in this press release or similar oral statements for purposes of the U.S. federal securities laws or otherwise, although not all forward-looking statements include such words. Such statements are “forward looking” statements, as such term is defined in the Private Securities Litigation Reform Act of 1995, and involve assumptions, risks and uncertainties, all of which can change over time. Actual results could differ materially from those expressed or implied in these forward-looking statements for any reason.  Risks and uncertainties specific to FSAM include (a) that FSAM has limited to no revenue generating operations, (b) that future dividends and distributions of proceeds relating to the transaction with Oaktree to FSAM Class A stockholders must be declared by the FSAM Board, subject to applicable law, (c) that any amounts distributed to FSAM Class A stockholders may not be reflective of the price at which any investor has purchased, or may purchase, shares of FSAM Class A common stock and (d) that ongoing operational costs at FSAM and its subsidiaries and potential wind-down costs may impact amounts that may be available for distribution by FSAM to its Class A stockholders. FSAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

CONTACT:

Investor Contact:
Robyn Friedman
(561) 510-2293
[email protected]

 

Posted on

3D Systems Unveils Advancements in Creation of World’s Largest, Fastest Powder Metal 3D Printer for CCDC Army Research Laboratory

  • New solution will revolutionize key supply chains associated with long-range munitions, next-generation combat vehicles, helicopters, air and missile defense capabilities
  • First test print completed on unique 9-laser, 1m x 1m x 600mm metal 3D printer

ROCK HILL, S.C., Nov. 12, 2020 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today announced it has achieved significant progress in the creation of the world’s largest, fastest most precise powder metal 3D printer. Through a combination of multiple lasers, large build chamber, and unique material deposition processes, the Company is poised to enable the Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) with technology designed to address their specific application needs for long-range munitions, next-generation combat vehicles, helicopters, air and missile defense capabilities. This unparalleled additive manufacturing solution – comprising materials, hardware, software and services – reinforces 3D Systems’ dedication to customer-centric innovation, creating value through solutions designed to address its customers’ unique application needs.

Since the $15 million contract award in the third quarter of 2019, 3D Systems’ engineering and applications experts have drawn upon their deep expertise and experience to develop a unique 9-laser, 1m x 1m x 600mm metal 3D printer which is the only of its kind in the industry.

“When we embarked on this project, we needed a faster way to produce critical components for major ground combat subsystems,” said Ms. Stephanie Koch, ARL’s Advanced Manufacturing, Materials, and Processes Program Manager. “The progress that has been made on this project to date is monumental. We look forward to the coming months as we progress to a full-scale production solution that will enable innovative new capabilities for transformational overmatch.”

“Development and demonstration of this first of its kind technology has far reaching implications across our industrial base as it shapes and transforms the supply chain around it,” said Lisa Strama, president and CEO of NCMS. “This project has also provided the unique ability to concurrently plan for and address a complex ecosystem for maximizing the benefit to US manufacturers’ competitiveness from the outset.”

At the end of October 2020, 3D Systems completed the first test print, using a selective powder deposition process. This unique concept limits the amount of material needed to produce very large parts by depositing the material only where it is needed in the build – accelerating time-to-final part and reducing material cost. The build chamber also includes a heated build plate to reduce thermal stress and also improve deposition quality during the build.

To create this next-generation platform, 3D Systems is leveraging key technologies from its Direct Metal Printing (DMP) platform, which is foundational to the Company’s DMP Flex 350, DMP Factory 350, and DMP Factory 500 3D printers. One of the most important components is the optical train that enables each of the next-generation printer’s nine lasers with its own melt pool monitoring system for enhanced quality control. By employing the same optical system as used in its DMP platform, the Company can leverage the existing material library which has been extensively tested and fine-tuned for optimal performance. Pulling from the data associated with these high-performance materials accelerates development of new materials.

The Company is also integrating its industry-renowned vacuum chamber concept for high, repeatable quality. 3D Systems’ inerting process is many times faster and consumes substantially less argon (at least ten times less) than conventional metal 3D printers. The inerting process dramatically reduces the oxygen level during processing to below 25ppm, which is revolutionary compared to the 500-1,000 ppm in most conventional metal 3D printers. This results in exceptionally strong parts of high chemical purity while powder quality remains high through the lifetime of the material’s usage. This results in a significantly reduced total purchase cost of compressed argon over machine lifetime as well as savings enabled by powder reusability for lower Total Cost of Operation.

The inclusion of six high contrast single-lens reflex (SLR) cameras within the build chamber delivers a comprehensive view of the build in-situ. Each camera is positioned above the powder bed with direct top-down view. This unique viewpoint eliminates the need for image manipulation, resulting in the ability to obtain build data real-time thus accelerating the process. The firmware within the system is capturing all digital input including sensor data, positional information, melt pool data and powder bed pictures into an SQL database. This enables full insight into the build and is invaluable for part and process validation and qualification. Additionally, 3D Systems is leveraging the same proven additive manufacturing software used within its DMP platform to optimize designs and streamline processes to accelerate print times and reduce material consumption.

“3D Systems was founded on a spirit of innovation, and our customers play a key role in catalyzing this process,” said Chuck Hull, co-founder and chief technology officer, 3D Systems. “Our collaboration with ARL is allowing us to elevate our research and development efforts, achieving many industry firsts on our way to empowering the ARL to meet their goals. Our accomplishments through the first phases of this project will fuel the next, on our way to helping ARL scale their capabilities and bolstering their supply chain.”

According to the U.S. Army Additive Manufacturing Implementation Plan, the Army has been using additive manufacturing (AM) for two decades to refurbish worn parts and create custom tools. Once developed, the Army will leverage its manufacturing experience by placing the new large-scale systems in its depots and labs. Subsequently, 3D Systems and its partners plan to make the new 3D printer technology available to leading aerospace and defense suppliers for the development of futuristic Army platforms.

Forward-Looking Statements

Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as “believes,” “belief,” “expects,” “may,” “will,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or review any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise.

About 3D Systems

More than 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading Additive Manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction – empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in Healthcare and Industrial markets such as Medical and Dental, Aerospace & Defense, Automotive, and Durable Goods. More information on the company is available at www.3dsystems.com.

About NCMS

The National Center for Manufacturing Sciences (NCMS) is a cross-industry technology development consortium, dedicated to improving the competitiveness and strength of the U.S. industrial base. As a member-based organization, it leverages its network of industry, government, and academia partners to develop, demonstrate, and transition innovative technologies efficiently, with less risk and lower cost. The NCMS is proud to work with the Army Research Laboratory (ARL) and the Advanced Manufacturing, Materials, and Processes (AMMP) program to advance and enable additive manufacturing to create next-generation manufacturing breakthroughs. AMMP will respond to requirements for affordable, complex parts that currently cannot be readily built. For more information, visit www.ncms.org/ammp.

Investor Contact: [email protected]
Media Contact: [email protected]

Posted on

Q2 Holdings, Inc. Announces Private Convertible Exchange and Subscription Transactions of $350 Million Principal Amount of 0.125% Convertible Senior Notes Due 2025

Q2 Holdings, Inc. Announces Private Convertible Exchange and Subscription Transactions of $350 Million Principal Amount of 0.125% Convertible Senior Notes Due 2025

AUSTIN, Texas–(BUSINESS WIRE)–
Q2 Holdings, Inc. (“Q2“) (NYSE: QTWO), a leading provider of digital transformation solutions for banking and lending, announced that it has entered into privately negotiated exchange and/or subscription agreements, with certain holders of its outstanding 0.75% Convertible Senior Notes due 2023 (the “2023 Notes“) and certain new investors pursuant to which Q2 will issue $350 million principal amount of 0.125% Convertible Senior Notes due 2025 (the “New Notes“) consisting of (a) $210.7 million of New Notes and either shares of Q2’s common stock or cash in exchange for approximately $181.9 million principal amount of the 2023 Notes (the “Exchange Transactions“) and (b) $139.3 million principal amount of New Notes for cash (the “Subscription Transactions“), in each case, pursuant to exemptions from registration under the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations thereunder. Following the closing of the Exchange Transactions, $48.1 million in aggregate principal amount of 2023 Notes will remain outstanding with terms unchanged. The Exchange Transactions and the Subscription Transactions are expected to close concurrently on or about November 18, 2020, subject to customary closing conditions.

The New Notes will represent senior unsecured obligations of Q2 and will pay interest semi-annually in arrears on each May 15 and November 15, commencing on May 15, 2021, at a rate of 0.125% per annum. The New Notes will mature on November 15, 2025, unless earlier converted, redeemed or repurchased. Prior to the close of business on the business day immediately preceding August 15, 2025, the New Notes will be convertible at the option of holders only upon the satisfaction of certain conditions and during certain periods. On or after August 15, 2025, until close of business on the second scheduled trading day preceding maturity, the New Notes will be convertible at the option of the holders at any time regardless of these conditions. The New Notes will be convertible into cash, shares of Q2’s common stock or a combination of cash and Q2’s common stock, at Q2’s election. The initial conversion rate is 7.1355 shares of Q2’s common stock per $1,000 principal amount of New Notes, which is equivalent to an initial conversion price of approximately $140.14 per share, and will be subject to customary anti-dilution adjustments. On or after November 20, 2023, Q2 may redeem for cash all or any portion of the New Notes if the last reported sale price of Q2’s common stock has been at least 130% of the conversion price for the New Notes for at least 20 trading days during any 30 consecutive trading day period.

If Q2 undergoes a fundamental change (as defined in the indenture governing the New Notes), holders may require Q2 to purchase for cash all or part of their New Notes at a purchase price equal to 100% of the principal amount of the Convertible Notes to be purchased, plus accrued and unpaid interest, if any, up to, but excluding, the fundamental change repurchase date. In addition, if certain make-whole fundamental changes occur or Q2 calls the New Notes for redemption, Q2 will, in certain circumstances, increase the conversion rate for any New Notes converted in connection with such make-whole fundamental change or redemption.

Q2 will not receive any cash proceeds from the Exchange Transactions. In exchange for issuing the New Notes pursuant to the Exchange Transactions, Q2 will receive and cancel the exchanged 2023 Notes. Q2 estimates that net cash proceeds from the Subscription Transactions will be approximately $132.1 million after deducting estimated offering expenses for both the Exchange Transactions and the Subscription Transactions. Q2 intends to use net cash proceeds from the Subscription Transactions to pay the cost of the capped call transactions described below and for general corporate purposes.

In connection with the exchange and/or subscription agreements, Q2 entered into capped call transactions with certain dealers (the “Option Counterparties”). The capped call transactions are expected generally to reduce the potential dilution to Q2’s common stock upon any conversion of New Notes and/or offset any cash payments Q2 is required to make in excess of the principal amount of converted New Notes, as the case may be, in each case upon conversion of the New Notes.

Q2 expects that in connection with establishing their initial hedges of these transactions, the Option Counterparties and/or their respective affiliates will enter into various derivative transactions with respect to Q2’s common stock and/or purchase Q2’s common stock in secondary market transactions concurrently with, or shortly after, the pricing of the New Notes. This activity could increase (or reduce the size of any decrease in) the market price of Q2’s common stock or the New Notes at that time. In addition, Q2 expects that the Option Counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Q2’s common stock and/or purchasing or selling Q2’s common stock or other securities of Q2 in secondary market transactions following the pricing of the New Notes and prior to the maturity of the New Notes (and are likely to do so during any observation period related to a conversion of New Notes). This activity could also cause or avoid an increase or a decrease in the market price of Q2’s common stock or the New Notes, which could affect the ability of holders of New Notes to convert the New Notes and, to the extent the activities occur during any observation period related to a conversion of the New Notes, could affect the amount of cash and/or the number and value of shares of Q2 common stock that holders will receive upon conversion of the New Notes.

In connection with the issuance of the 2023 Notes, Q2 entered into convertible note hedge transactions (the “Existing Convertible Note Hedge Transactions”) with certain financial institutions (the “Existing Option Counterparties”). Q2 also entered into separate warrant transactions (the “Existing Warrant Transactions”) with the Existing Option Counterparties. In connection with the exchange transactions with respect to the 2023 Notes, Q2 entered into agreements with the Existing Option Counterparties to terminate a portion of: (i) the Existing Convertible Note Hedge Transactions in a notional amount corresponding to the principal amount of such 2023 Notes exchanged and (ii) the Existing Warrant Transactions with respect to a number of shares equal to the notional shares underlying such 2023 Notes exchanged. In connection with such terminations and the related unwinding of the existing hedge position of the existing counterparties with respect to such transactions, such Existing Option Counterparties and/or their respective affiliates may sell shares of Q2’s common stock in secondary market transactions, and/or unwind various derivative transactions with respect to the common stock concurrently with or shortly after the pricing of the New Notes.

In connection with such terminations, Q2 anticipates that it will receive net proceeds from the Existing Option Counterparties equal to approximately $34.1 million, which it intends to use for general corporate purposes. The exchange of Q2’s 2023 Notes and the unwind of the Existing Convertible Note Hedge Transactions and the Existing Warrant Transactions described above, and the potential related market activities by exchanging holders of the 2023 Notes and the existing counterparties, as applicable, could increase (or reduce the size of any decrease in) or decrease (or reduce the size of any increase in) the market price of Q2’s common stock, which may affect the trading price of the notes, at that time and Q2 cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes or its common stock.

The New Notes, any shares of common stock issued in the Exchange Transactions and any shares issuable upon conversion of the New Notes have not been registered under the Securities Act or under any state securities laws and may not be offered or sold without registration under, or an applicable exemption from, the registration requirements. This announcement does not constitute an offer to sell, nor is it a solicitation of an offer to buy, these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or any jurisdiction.

Forward-looking Statements:

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the planned offering. Words such as “anticipates,” “estimates,” “expects,” “projects,” “forecasts,” “intends,” “plans,” “will,” “believes” and words and terms of similar substance used in connection with any discussion identify forward-looking statements. These forward-looking statements are based on management’s current expectations and beliefs about future events and are inherently susceptible to uncertainty and changes in circumstances. Except as required by law, Q2 is under no obligation to, and expressly disclaim any obligation to, update or alter any forward-looking statements whether as a result of such changes, new information, subsequent events or otherwise. With respect to the Exchange Transactions and the Subscription Transactions, such uncertainties and circumstances include whether Q2 will consummate the Exchange Transactions and the Subscription Transactions, and the use of the net proceeds from the Subscription Transactions. Various factors could also adversely affect Q2’s operations, business or financial results in the future and cause Q2’s actual results to differ materially from those contained in the forward-looking statements, including those factors discussed in detail in the “Risk Factors” sections contained in Q2’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020, each filed with the Securities and Exchange Commission and available on the SEC Filings section of the Investor Services section of Q2’s website at http://investors.q2.com/.

About Q2 Holdings, Inc.

Q2 is a financial experience company dedicated to providing digital banking and lending solutions to banks, credit unions, alternative finance, and fintech companies in the U.S. and internationally. With comprehensive end-to-end solution sets, Q2 enables its partners to provide cohesive, secure, data-driven experiences to every account holder – from consumer to small business and corporate. Headquartered in Austin, Texas, Q2 has offices throughout the world and is publicly traded on the NYSE under the stock symbol QTWO.

Media Contact:

Beth Williams

Q2 Holdings, Inc.

O: 512.685.2023

[email protected]

Investor Contact:

Josh Yankovich

Q2 Holdings, Inc.

O: (512) 682-4463

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Security Professional Services Other Professional Services Technology Software

MEDIA:

Posted on

Better Choice Launches New Corporate and Store Websites Designed to Meet Increasing Consumer Demand and Expand Investor Awareness

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness company, has launched a newly designed corporate website in support of its fast growing brand portfolio and to better communicate with the investing community. The Company also debuted a new online store for its high-growth TruDog brand (https://trudog.com/).

Michael Young, Chairman of Better Choice, stated, “We are extremely happy with the design and functionality of our new websites as they greatly enhance our capabilities to serve and support our customer-facing stores. The new designs help to expedite all processes to meet the increasing demand we are seeing across all of our platforms and brands. And for investors, our new corporate site is more effective in providing business updates, news, and timely financial and industry information.”

Visit the new corporate site at: https://www.betterchoicecompany.com and the new TruDog online store at: https://trudog.com/.

About Better Choice Company, Inc.

Better Choice Company Inc. is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. We take an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted animal health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

Better Choice Company, Inc.
Werner von Pein, CEO

Investor Contact:

RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Posted on

DATA443 SCHEDULES BUSINESS UPDATE CONFERENCE CALL ON THURSDAY, NOVEMBER 19 AT 4:30 PM ET

RESEARCH TRIANGLE PARK, NC, Nov. 12, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (“Data443” or the “Company”) (OTCPK: ATDS), a leading data security and privacy software company, today announced that the Company will host a business update conference call on Thursday, November 19th at 4:30 PM ET.

Investors and other interested parties may submit their questions ahead of time by emailing Investor Relations at [email protected] – Online registration is available at: https://us02web.zoom.us/webinar/register/WN_3yfYIRn2S2ikdr2agg16nw.

About Data443 Risk Mitigation, Inc.

Data443 Risk Mitigation, Inc. (OTCPK: ATDS), is the de facto industry leader in Data Privacy Solutions for All Things Data Security™, providing software and services to enable secure data across local devices, network, cloud, and databases, at rest and in flight. Its suite of products and services is highlighted by: (i) ARALOC™, which is a market leading secure, cloud-based platform for the management, protection and distribution of digital content to the desktop and mobile devices, which protects an organization’s confidential content and intellectual property assets from leakage — malicious or accidental — without impacting collaboration between all stakeholders; (ii) DataExpress®, the leading data transport, transformation and delivery product trusted by leading financial organizations worldwide; (iii) ArcMail™, which is a leading provider of simple, secure and cost-effective email and enterprise archiving and management solutions; (iv) ClassiDocs® the Company’s award-winning data classification and governance technology, which supports CCPA, LGPD, and GDPR compliance; (v) ClassiDocs® for Blockchain, which provides an active implementation for the Ripple XRP that protects blockchain transactions from inadvertent disclosure and data leaks; (vi) Data443® Global Privacy Manager, the privacy compliance and consumer loss mitigation platform which is integrated with ClassiDocs® to do the delivery portions of GDPR and CPRA (previously, CCPA) as well as process Data Privacy Access Requests – removal request – with inventory by ClassiDocs™; (vii) Resilient AccessTM, which enables fine-grained access controls across myriad platforms at scale for internal client systems and commercial public cloud platforms like Salesforce, Box.Net, Google G Suite, Microsoft OneDrive and others; viii) Data443™ Chat History Scanner, which scans chat messages for Compliance, Security, PII, PI, PCI & custom keywords; (ix) the CPRA Framework WordPress plugin, which enables organizations of all sizes to comply with the CPRA privacy framework; (x) FileFacets™, a Software-as-a-Service (SaaS) platform that performs sophisticated data discovery and content search of structured and unstructured data within corporate networks, servers, content management systems, email, desktops and laptops; and (xi) the GDPR Framework WordPress plugin, with over 30,000 active users and over 400,000 downloads it enables organizations of all sizes to comply with the GDPR and other privacy frameworks. For more information, please visit http://www.data443.com.

Forward-Looking Statements 

The statements contained in this release that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “could,” “should,” “expect,” “plan,” “project,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “pursuant,” “target,” “continue,” and similar expressions are intended to identify such forward-looking statements. The statements in this press release that are not historical statements, including statements regarding Data443’s plans, objectives, future opportunities for Data443’s services, future financial performance and operating results and any other statements regarding Data443’s future expectations, beliefs, plans, objectives, financial conditions, assumptions or future events or performance that are not historical facts, are forward-looking statements within the meaning of the federal securities laws. These statements are not guarantees of future performance and are subject to numerous risks, uncertainties, and assumptions, many of which are beyond Data443’s control, and which could cause actual results to differ materially from the results expressed or implied by the statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, and include, without limitation, results of litigation, settlements and investigations; actions by third parties, including governmental agencies; volatility in customer spending; global economic conditions; ability to hire and retain personnel; loss of, or reduction in business with, key customers; difficulty with growth and integration of acquisitions; product liability; cybersecurity risk; anti-takeover measures in our charter documents; and, the uncertainties created by the ongoing outbreak of a respiratory illness caused by the 2019 novel coronavirus that was recently named by the World Health Organization as COVID-19. These and other important risk factors are described more fully in our reports and other documents filed with the Securities and Exchange Commission (“the SEC”), including under (i) “Part I, Item 1A. Risk Factors”, in our Registration Statement on Form 10 filed with the SEC on January 11, 2019 and amended on April 24, 2019; (ii) “Part I, Item 1A. Risk Factors”, in our Annual Report on Form 10-K filed with the SEC on 17 April 2020; and, (iii) subsequent filings. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

The Data443® logo, ClassiDocs® logo, ARALOC™ logo and DataExpress® are registered trademarks of Data443 Risk Mitigation, Inc.

All product names, trademarks and registered trademarks are property of their respective owners.

All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks and brands does not imply endorsement.

All other trademarks cited herein are the property of their respective owners.

For Further Information:

Follow us on Twitter: https://twitter.com/data443Risk
Follow us on Facebook: https://www.facebook.com/data443/
Follow us on LinkedIn: https://www.linkedin.com/company/data443-risk-mitigation-inc/
Signup for our Investor Newsletter: https://www.data443.com/investor-relations/

Investor Relations Contact:
Matthew Abenante
[email protected]
919.858.6542

Posted on

Cerus Corporation to Participate in Upcoming Virtual Investor Conferences

Cerus Corporation to Participate in Upcoming Virtual Investor Conferences

CONCORD, Calif.–(BUSINESS WIRE)–
Cerus Corporation (Nasdaq: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in two conferences:

  • The Stifel Virtual Healthcare Conference on Monday, November 16th at 1:20 P.M. ET.
  • The Stephens Annual Investment Conference on Thursday, November 19th at 3:00 P.M. ET.

A live webcast of the events will be available on the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Based in Concord, California, our employees are dedicated to deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval for pathogen reduction of both platelet and plasma components. Cerus currently markets and sells the INTERCEPT Blood System in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT Red Blood Cell system is in clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Jessica Hanover – VP, Corporate Affairs

Cerus Corporation

925-288-6137

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Biotechnology Health Medical Supplies Medical Devices

MEDIA:

Logo
Logo
Posted on

SPX Announces Purchase of Sensors & Software Inc.

CHARLOTTE, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) — SPX Corporation (NYSE:SPXC) today announced that it has completed the acquisition of Sensors & Software Inc. (“Sensors & Software”), based in Mississauga, Ontario. Sensors & Software is a manufacturer and distributor of Ground Penetrating Radar (GPR) products used for locating underground utilities, detecting unexploded ordinance, and geotechnical and geological investigations.

“We are excited about Sensors & Software joining the SPX team,” said Gene Lowe, President and CEO of SPX Corporation. “Sensors & Software is a leader in GPR applications, with a strong brand, technology and user base that make it a highly complementary addition to our Radiodetection business’ industry-leading portfolio of cable and pipe locator and other detection and measurement products. We expect this combination to drive incremental value by leveraging our combined products, technologies, sales networks and channels.”

The company’s results will be reported as a part of SPX’s Radiodetection business unit. After taking into account intercompany sales, Sensors & Software is anticipated to contribute $6-8 million of annual revenue and to be modestly accretive to the margin profile of the Detection & Measurement segment.

About SPX Corporation:  SPX Corporation is a supplier of highly engineered products and technologies, holding leadership positions in the HVAC, detection and measurement, and engineered solutions markets. Based in Charlotte, North Carolina, SPX Corporation had approximately $1.5 billion in annual revenue in 2019 and over 4,500 employees in 17 countries. SPX Corporation is listed on the New York Stock Exchange under the ticker symbol “SPXC.”  For more information, please visit www.spx.com.

About
Sensors & Software
Inc.
:  Headquartered in Mississauga, Ontario, Sensors & Software is the worldwide leader of Ground Penetrating Radar innovations. The company offers a wide range of hardware and software products and services designed to understand what lies beneath the surface and empower informed decision-making. For more information, please visit www.sensoft.ca.

SOURCE SPX Corporation.

Investor
and Media
Contacts:

Paul Clegg, VP, Investor Relations and Communications
Phone:  980-474-3806
E-mail: [email protected]